Leo Lee Tsai, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphedema | 14 | 2023 | 525 | 3.940 |
Why?
|
Lymphatic Vessels | 5 | 2023 | 358 | 1.670 |
Why?
|
Lymphography | 7 | 2023 | 188 | 1.520 |
Why?
|
Liver Neoplasms | 7 | 2024 | 4321 | 1.090 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2024 | 2299 | 0.970 |
Why?
|
Magnetic Resonance Imaging | 27 | 2024 | 36430 | 0.810 |
Why?
|
Helium | 3 | 2008 | 119 | 0.660 |
Why?
|
Asymptomatic Diseases | 1 | 2022 | 587 | 0.650 |
Why?
|
Pancreatitis | 2 | 2023 | 1096 | 0.620 |
Why?
|
Organometallic Compounds | 1 | 2021 | 648 | 0.600 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 104 | 0.580 |
Why?
|
Upper Extremity | 5 | 2023 | 657 | 0.580 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3161 | 0.500 |
Why?
|
Radiology | 3 | 2020 | 2113 | 0.500 |
Why?
|
Prostate | 5 | 2024 | 1770 | 0.500 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 642 | 0.500 |
Why?
|
Splenosis | 1 | 2014 | 4 | 0.490 |
Why?
|
Posture | 3 | 2008 | 956 | 0.460 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4246 | 0.450 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 190 | 0.420 |
Why?
|
Vagina | 1 | 2018 | 838 | 0.410 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5363 | 0.410 |
Why?
|
Neurofibroma, Plexiform | 1 | 2012 | 66 | 0.380 |
Why?
|
Arm | 3 | 2023 | 590 | 0.370 |
Why?
|
Sulfonamides | 1 | 2020 | 1976 | 0.370 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 168 | 0.360 |
Why?
|
Prostatic Hyperplasia | 2 | 2023 | 521 | 0.310 |
Why?
|
Spleen | 1 | 2014 | 2296 | 0.310 |
Why?
|
Pyrimidines | 1 | 2020 | 3025 | 0.310 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 570 | 0.300 |
Why?
|
Coronary Circulation | 1 | 2013 | 1565 | 0.290 |
Why?
|
Lymphatic System | 3 | 2023 | 254 | 0.280 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 560 | 0.280 |
Why?
|
Transducers | 1 | 2008 | 241 | 0.280 |
Why?
|
Carcinoma | 1 | 2018 | 2328 | 0.270 |
Why?
|
Lower Extremity | 3 | 2023 | 1201 | 0.260 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2022 | 1726 | 0.250 |
Why?
|
Artifacts | 1 | 2013 | 1910 | 0.240 |
Why?
|
Omentum | 2 | 2023 | 168 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5665 | 0.230 |
Why?
|
Indocyanine Green | 2 | 2022 | 233 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2009 | 0.220 |
Why?
|
Isotopes | 3 | 2008 | 125 | 0.220 |
Why?
|
Middle Aged | 24 | 2024 | 220774 | 0.220 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 107 | 0.220 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21009 | 0.210 |
Why?
|
Lactates | 1 | 2024 | 405 | 0.210 |
Why?
|
Pyruvic Acid | 1 | 2024 | 204 | 0.210 |
Why?
|
Rats, Inbred F344 | 1 | 2024 | 826 | 0.210 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 33 | 0.210 |
Why?
|
Retrospective Studies | 19 | 2024 | 80575 | 0.210 |
Why?
|
Lymph Nodes | 4 | 2023 | 3469 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2821 | 0.200 |
Why?
|
Spin Labels | 2 | 2020 | 337 | 0.200 |
Why?
|
Abdominal Cavity | 1 | 2022 | 34 | 0.200 |
Why?
|
Humans | 46 | 2024 | 761326 | 0.200 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6478 | 0.190 |
Why?
|
Microspheres | 1 | 2024 | 785 | 0.180 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 195 | 0.180 |
Why?
|
Lung | 3 | 2008 | 9994 | 0.180 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2022 | 187 | 0.180 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 66 | 0.180 |
Why?
|
Heart | 1 | 2013 | 4405 | 0.170 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11116 | 0.170 |
Why?
|
Quality of Life | 3 | 2021 | 13355 | 0.170 |
Why?
|
Female | 25 | 2024 | 392485 | 0.170 |
Why?
|
Postoperative Complications | 1 | 2022 | 15647 | 0.170 |
Why?
|
Appendiceal Neoplasms | 1 | 2022 | 155 | 0.170 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2019 | 100 | 0.160 |
Why?
|
Lipectomy | 1 | 2020 | 113 | 0.160 |
Why?
|
Edema | 1 | 2023 | 770 | 0.160 |
Why?
|
Indazoles | 1 | 2020 | 302 | 0.160 |
Why?
|
Pancreas | 2 | 2023 | 1689 | 0.160 |
Why?
|
Rats | 3 | 2024 | 23729 | 0.150 |
Why?
|
Cryosurgery | 1 | 2023 | 474 | 0.150 |
Why?
|
Glycolysis | 1 | 2022 | 836 | 0.150 |
Why?
|
Drug Resistance | 1 | 2024 | 1597 | 0.150 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2018 | 198 | 0.150 |
Why?
|
alpha-Fetoproteins | 1 | 2018 | 223 | 0.150 |
Why?
|
Radionuclide Imaging | 1 | 2021 | 1975 | 0.150 |
Why?
|
Free Tissue Flaps | 1 | 2022 | 331 | 0.140 |
Why?
|
Image Enhancement | 1 | 2008 | 2884 | 0.140 |
Why?
|
Lactic Acid | 1 | 2022 | 1137 | 0.140 |
Why?
|
Perineum | 1 | 2018 | 208 | 0.140 |
Why?
|
Extremities | 1 | 2021 | 867 | 0.130 |
Why?
|
Prostatectomy | 1 | 2024 | 1824 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2024 | 1375 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3356 | 0.120 |
Why?
|
Male | 21 | 2024 | 360621 | 0.120 |
Why?
|
Urologic Neoplasms | 1 | 2018 | 313 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12972 | 0.120 |
Why?
|
Aged | 11 | 2024 | 169179 | 0.120 |
Why?
|
Device Approval | 1 | 2015 | 163 | 0.110 |
Why?
|
Splenectomy | 1 | 2014 | 391 | 0.110 |
Why?
|
Attitude to Computers | 1 | 2013 | 196 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7238 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4355 | 0.100 |
Why?
|
Risk Management | 1 | 2015 | 558 | 0.100 |
Why?
|
Prospective Studies | 6 | 2022 | 54405 | 0.100 |
Why?
|
Equipment Design | 3 | 2008 | 3510 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2423 | 0.090 |
Why?
|
Computers, Handheld | 1 | 2013 | 209 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3082 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 26108 | 0.090 |
Why?
|
Contrast Media | 3 | 2021 | 5310 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 362 | 0.090 |
Why?
|
Insulin | 1 | 2024 | 6595 | 0.080 |
Why?
|
Radiography | 1 | 2020 | 6966 | 0.080 |
Why?
|
Occupational Health | 1 | 2015 | 806 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1272 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14665 | 0.080 |
Why?
|
Administration, Inhalation | 2 | 2008 | 1156 | 0.070 |
Why?
|
Trachea | 1 | 2014 | 1089 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2021 | 2752 | 0.070 |
Why?
|
Organ Size | 2 | 2023 | 2252 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4345 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 696 | 0.070 |
Why?
|
Cell Proliferation | 1 | 2022 | 10431 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2024 | 64645 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3531 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2014 | 1329 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 847 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 5 | 2023 | 20555 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11070 | 0.060 |
Why?
|
Adult | 6 | 2023 | 221122 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12949 | 0.060 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2023 | 74 | 0.050 |
Why?
|
Algorithms | 2 | 2021 | 14025 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8704 | 0.050 |
Why?
|
Animals | 3 | 2024 | 168388 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2650 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6332 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15835 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2023 | 58946 | 0.050 |
Why?
|
Chronic Disease | 3 | 2022 | 9319 | 0.050 |
Why?
|
Elbow | 1 | 2021 | 130 | 0.040 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2021 | 112 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12144 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7389 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2018 | 511 | 0.040 |
Why?
|
Pelvis | 1 | 2022 | 732 | 0.040 |
Why?
|
Necrosis | 1 | 2020 | 1605 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2024 | 3588 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 740 | 0.030 |
Why?
|
Preoperative Care | 1 | 2024 | 2242 | 0.030 |
Why?
|
Adolescent | 3 | 2019 | 88305 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4063 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1089 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1374 | 0.030 |
Why?
|
Mastectomy | 1 | 2023 | 1822 | 0.030 |
Why?
|
Goals | 1 | 2019 | 711 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2648 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2022 | 1495 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2469 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29858 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5877 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5247 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22158 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2914 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 29588 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2014 | 276 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2018 | 1671 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36202 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6768 | 0.020 |
Why?
|
Blood Glucose | 1 | 2024 | 6389 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42251 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7852 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7531 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 59196 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9275 | 0.020 |
Why?
|
Incidence | 1 | 2022 | 21336 | 0.010 |
Why?
|
Child | 1 | 2012 | 80156 | 0.010 |
Why?
|
Stents | 1 | 2014 | 3179 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39108 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9333 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2014 | 2181 | 0.010 |
Why?
|